Zobrazeno 1 - 5
of 5
pro vyhledávání: '"María del Pilar Valdés A"'
Publikováno v:
Revista Chilena de Dermatología. 31
La ciclosporina (Cs) es un agente sistémico efectivo en psoriasis, que actúa inhibiendo la activación de linfocitos T. Se caracteriza por presentar un rápido inicio de acción, siendo una buena herramienta terapéutica en crisis psoriáticas, com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb3a46cb57e03fb6b9977764bdbe9299
https://doi.org/10.31879/rcderm.v31i4.22
https://doi.org/10.31879/rcderm.v31i4.22
Autor:
María Del Pilar, Valdés A, Francisca, Schroeder H, Vicky, Roizen G, Juan, Honeyman M, Leonardo, Sánchez M
Publikováno v:
Revista medica de Chile. 134(3)
Psoriasis has a moderate or severe course in 25% of patients, requiring systemic therapy that is not always successful. Infliximab is a human-murine monoclonal anti tumor necrosis alpha (TNF-alpha) antibody. This mediator has a role in the pathogenes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c8626adf6e43fb1d0d9e305488c9296f
https://pubmed.ncbi.nlm.nih.gov/16676105
https://pubmed.ncbi.nlm.nih.gov/16676105
Autor:
Francisca Schroeder H, Leonardo Sánchez M, María del Pilar Valdés A, Vicky Roizen G., Juan Honeyman M
Publikováno v:
Revista médica de Chile v.134 n.3 2006
SciELO Chile
CONICYT Chile
instacron:CONICYT
SciELO Chile
CONICYT Chile
instacron:CONICYT
Background: Psoriasis has a moderate or severe course in 25% of patients, requiring systemic therapy that is not always successful. Infliximab is a human-murine monoclonal anti tumor necrosis alpha (TNF-a) antibody. This mediator has a role in the pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f4b1e97f8456c2bcb98c2842f3475f9
https://doi.org/10.4067/s0034-98872006000300009
https://doi.org/10.4067/s0034-98872006000300009